Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
Roni Nielsen(Aarhus University), Henrik Wiggers(Aarhus University Hospital), Nils Henrik Hansson(Aarhus University Hospital), Hendrik J. Harms(Amsterdam UMC Location VUmc), Thomas Ravn Lassen(Aarhus University), Lars Poulsen Tolbod(Aarhus University Hospital), Jørgen Frøkiær(Canon (Japan)), Lars Christian Gormsen(Aarhus University), Jens Nørkær Sørensen(Uppsala University), Niels Møller(Aarhus University Hospital), Hans Eiskjær(Aarhus University Hospital), Kasper Pryds(Aarhus University), Nichlas Riise Jespersen(Aarhus University), Søren Mellemkjær(Aarhus University Hospital), Hans Erik Bøtker(Aarhus University)
Cited by 513
Related Papers
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
|New England Journal of Medicine|2016|1.7k
Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease
|Journal of the American College of Cardiology|2014|1.5k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|714
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335